drugset / Trial / NCT04867200

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

NCT04867200

Phase 1 Unknown 60 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical Trial to evaluate the Pharmacokinetics and safety of CKD-344

Timeline

Start
2021-04-27
Primary completion
2021-05-25
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-344 Unknown 60 mg
Subject Edoxaban Small molecule 60 mg

Indications

No indication recorded.